Home Health Mpox: WHO Approves Administration of Jynneos Vaccine for Adolescents
HealthNews

Mpox: WHO Approves Administration of Jynneos Vaccine for Adolescents

303

On Monday, the World Health Organisation (WHO) announced its approval of Bavarian Nordic’s Jynneos vaccine for adolescents aged 12 to 17. This group is considered particularly vulnerable to mpox outbreaks. The vaccine was prequalified by the WHO on October 8, 2024, following its earlier approval for adults.

The approval comes after the European Union authorised the vaccine for adolescents in September. The WHO declared mpox a global public health emergency in August, after a new strain of the virus spread across many countries.

Bavarian Nordic is set to begin clinical trials to assess the vaccine’s safety for children aged two to 12. The trials are expected to start in October. Meanwhile, the U.S. FDA has approved the vaccine for adults.

Another mpox vaccine, LC16, developed by Japan’s KM Biologics, is already approved for use in children but requires a specialised needle for administration.

Read More:

About The Author

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

NewsSecurity

Nigeria: BADA Raises Alarm as Militia Seize 20 of 23 LGAs in Benue State While Tinubu Remains Silent

The Benue Democratic Ambassadors (BEDA) have raised alarm over relentless militia attacks...

NewsSecurity

Nigeria: Armed Militia Attacks Benue, 85 Killed in One Week, 43 in Latest Attack

At least 43 people were reportedly killed on Sunday evening when armed...

Air Force Personnel Killed
NewsSecurity

Nigeria: Military Air Strike Mistakenly Kills 20 Vigilantes Chasing Armed Militias in Zamfara

At least 20 people were killed over the weekend in Zamfara State...

Niger
NewsSecurity

Niger Accuses France, Western Allies of Sabotage and Supporting Terrorism in Sahel

Niger’s President Abdourahmane Tchiani has accused France and its Western Allies of...